Literature DB >> 11702601

The impact of biology on the treatment of secondary AML.

I Gojo1, J E Karp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11702601     DOI： 10.1007/978-1-4615-1463-3_12

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  1 in total

1.  Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias.

Authors:  Ivana Gojo; Anchalee Jiemjit; Jane B Trepel; Alex Sparreboom; William D Figg; Sandra Rollins; Michael L Tidwell; Jacqueline Greer; Eun Joo Chung; Min-Jung Lee; Steven D Gore; Edward A Sausville; James Zwiebel; Judith E Karp
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.